SEC Form 4 · accession 0001354488-15-002902
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wen Tao Liu
Officer — Executive Chairman · Director
Period of report
Jun 1, 2015
Accepted (ET)
Jun 10, 2015 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2015 | M | 33,333 | $3.00 | A | 224,076 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option | $3.00 | Jun 1, 2015 | M | 33,333 | A | Feb 20, 2015 | Feb 20, 2023 | Common Stock | 33,333 | 0 | D |